is it safe to take semaglutide for weight loss What the Dose Loss? How Do You Know When

Shorter periods may show initial response but do not capture full potential

(2024) MASLD/Liver Fat Substudy Study Design: Substudy evaluating liver fat and metabolic dysfunction-associated steatotic liver disease (MASLD) in participants receiving retatrutide

Falls, fractures, and functional decline are real risks if muscle loss is not actively prevented during pharmacological weight reduction

24-week treatment period

These combined effects explain why many patients experience weight loss alongside improved glycaemic control

Retatrutide works by targeting specific pathways in the body that regulate appetite and energy expenditure, making it a potential game-changer for those struggling with obesity or metabolic disorders